Laboratorio Reig Jofre, S.A. (BME: RJF)
Health Care · Pharmaceuticals · ES
€2.66
+1.53% today · -13.9% 1Y
Laboratorio Reig Jofre, S.A. (BME: RJF) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $244.48M and employs 1,512 people.
Over the last twelve months the share price has lost 13.9%, trading between 2.32 and 3.14.
Tweenvest scores Laboratorio Reig Jofre, S.A. across four factors: quality 74/100, value 58/100, growth 28/100, dividend 42/100. Its strongest factor is quality.
RJF price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $244.48M
- Revenue (TTM)
- $385.85M
- P/E
- —
- EPS
- —
- Dividend yield
- 1.87%
- Beta (5Y)
- 0.94
- 52-week high
- €3.14
- 52-week low
- €2.32
- Avg volume (3M)
- —
- Shares outstanding
- 82.08M
- Employees
- 1,512
- Next earnings
- —
About Laboratorio Reig Jofre, S.A.
Laboratorio Reig Jofre, S.A. is a pharmaceutical company dedicated to the research, development, manufacturing, and commercialization of a diverse range of medicines and nutritional supplements. Its extensive portfolio encompasses prescription drugs, over-the-counter (OTC) products, medical devices, and cosmetics. The company's offerings are categorized into several key areas: advanced pharmaceutical technologies, which include antibiotics and injectable formulations; specialized healthcare solutions targeting dermatological, musculoskeletal (joint health and pain), women's health, respiratory/ENT, and pediatric needs; and consumer health items marketed under its Forté Pharma brand. Furthermore, Laboratorio Reig Jofre provides contract development and manufacturing (CDMO) as well as contract manufacturing organization (CMO) services. Founded in 1929 and headquartered in Sant Joan Despí, Spain, the company sells its products directly in seven countries and collaborates with business partners to reach approximately 70 other nations. It operates as a subsidiary of Reig Jofre Investments SL.
- ISIN
- ES0165359029
- Founded
- 1929
- Listed since
- Nov 29, 2002
- Exchange
- Bolsas y Mercados Espanoles
- Currency
- EUR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Venus Remedies LimitedBSE: 526953 | $247.73M | Rs1,784.40 | +6.84% |
| Cresco Labs Inc.CNSX: CL | $247.22M | CA$0.95 | -10.38% |
| AnnJi Pharmaceutical Co., Ltd.TPEX: 7754 | $247.16M | NT$78.00 | +7.88% |
| Ginwa Enterprise (Group) Inc.SHSE: 600080 | $244.97M | CN¥4.61 | -2.54% |
| HLB Pharmaceutical Co., Ltd.KOSDAQ: A047920 | $243.78M | ₩10,010.00 | +35.27% |
| Cipher Pharmaceuticals Inc.TSX: CPH | $243.45M | CA$13.65 | -0.07% |
| Kwang Dong Pharmaceutical Co., Ltd.KOSE: A009290 | $241.73M | ₩6,550.00 | +2.50% |
| Indoco Remedies LimitedNSEI: INDOCO | $241.35M | Rs251.75 | -1.07% |
Figures last refreshed Oct 4, 2026.